AMIODARONE HYDROCHLORIDE
Manufacturer: Medical Purchasing Solutions, LLC
Score: 145.0
Amiodarone Hydrochloride is an antiarrhythmic medication used to treat life-threatening irregular heartbeats, including ventricular fibrillation and hemodynamically unstable ventricular tachycardia. It is available in tablet form and has a complex pharmacokinetic profile. Amiodarone Hydrochloride is contraindicated in patients with cardiogenic shock, sick sinus syndrome, and known hypersensitivity to the drug or its components. It has several important safety warnings, including pulmonary, hepatic, and cardiac toxicity, and can cause adverse reactions such as visual impairment, thyroid abnormalities, and bradycardia. The recommended dosage is individualized based on the severity of the arrhythmia and response, with a typical loading dose of 800-1600 mg/day. Special population considerations include use during pregnancy, nursing mothers, pediatric patients, and geriatric patients.
Pulmonary, hepatic, and cardiac toxicity
Individualized based on response and severity of arrhythmia
Loading dose: 800-1600 mg/day for 1-3 weeks, followed by maintenance dose of 400 mg/day